Ron Bentsur - 10 May 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
10 May 2024
Net transactions value
+$12,800
Form type
4
Filing time
13 May 2024, 08:51:26 UTC
Previous filing
21 Mar 2024
Next filing
15 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $12,800 +2,000 +0.06% $6.40 3,244,484 10 May 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.31 to $6.44. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price
F2 Includes 426,759 shares of restricted stock.